Lower Oxygen Concentration for Preventing Collapsed Lung
(RESPIRA-EIT Trial)
Trial Summary
What is the purpose of this trial?
Patients undergoing general anesthesia require mechanical ventilation (artificial delivery of air and oxygen to their lungs). It is well known that during mechanical ventilation, so-called atelectasis formation occurs. This is a condition characterized by partial or complete collapse of lung tissue that can result in a reduction in oxygen uptake through the lung. A known risk factor for atelectasis formation during mechanical ventilation is the utilization of high oxygen concentration, as the oxygen molecules are absorbed in the lung, which then can lead to collapse of the tissue. Despite the proven association, standard operating procedure at the end of anesthesia still requires utilization of 100% oxygen. Its justification is the goal to ensure sufficient oxygenation throughout the extubation phase. However, clinical observation doesn't show a lack of oxygenation in this phase, but the patient is still exposed to the risk of atelectasis formation. This study aims to investigate the hypothesis of whether the utilization of reduced inspiratory oxygen concentration before extubation (70% or 40% compared to 100%) reduces atelectasis formation. The study was originally planned to randomize 24 patients to either 70% or 100% inspiratory oxygen concentration at the end of anaesthesia. After completion of this first phase, the study was amended to enroll another 24 patients randomized to 40% or 100% inspiratory oxygen concentration at the end of anaesthesia. Of note, both concentrations are still higher than when breathing room air in, which has of 21% oxygen. During the intervention, parameters such as the oxygen content in the blood (oxygen saturation, SpO₂), heart rate, and blood pressure are recorded, and atelectasis formation is measured using a technique called electrical impedance tomography (EIT). EIT measurements are performed at designated time points during the procedure. Anesthesia care providers are asked to document procedural, patient, and ventilator data in a questionnaire. Secondary outcomes are the homogeneity and distribution of air measured with EIT, as well as some clinical outcomes including post-extubation desaturation (\<90% SpO₂), incidence of re-intubation or non-invasive ventilation, and the Post-anesthesia Care Unit (PACU) length of stay.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment involving mechanical ventilation with reduced oxygen concentration for preventing collapsed lung?
Research suggests that while high oxygen levels can be harmful in some conditions, using a lower oxygen concentration during mechanical ventilation may help avoid potential lung damage. This approach aligns with findings that conservative oxygen therapy can be beneficial in managing severe respiratory conditions.12345
Is it safe to use lower oxygen concentrations in clinical trials for preventing collapsed lung?
Using high oxygen concentrations can have harmful effects, especially in certain conditions like chronic obstructive pulmonary disease (COPD) and heart issues. However, short-term use of high oxygen levels in controlled settings, like mechanical ventilation, has not shown injury in some studies. It's important to follow guidelines to avoid excessive oxygen use.12367
How does the treatment of ventilating with 70% oxygen concentration differ from other treatments for preventing collapsed lung?
This treatment is unique because it uses a lower oxygen concentration (70%) compared to the more common practice of using higher concentrations, like 100%, in mechanical ventilation. This approach aims to prevent lung injury that can occur with high oxygen levels while still providing sufficient oxygen to the patient.1891011
Eligibility Criteria
This trial is for adults over 18 who are having elective surgery with general anesthesia and endotracheal intubation, lasting between 1-5 hours. They must consent to participate in the study.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are randomly assigned to receive either 70% or 100% oxygen concentration during the washout phase before extubation. EIT measurements and other parameters are recorded.
Postoperative Monitoring
Participants are monitored in the PACU for 60 minutes post-extubation, with EIT measurements and SpO2 levels recorded.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including re-intubation or non-invasive ventilation needs within 7 days.
Treatment Details
Interventions
- Ventilating the patient with 70% oxygen concentration
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor